Kovack Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-17,030
| Closed | -$1.69M | – | 547 |
|
|
2019
Q3 | $1.69M | Sell |
17,030
-250
| -1% | -$24.8K | 0.35% | 67 |
|
|
2019
Q2 | $1.6M | Buy |
17,280
+7,491
| +77% | +$692K | 0.37% | 65 |
|
|
2019
Q1 | $923K | Sell |
9,789
-590
| -6% | -$55.6K | 0.23% | 115 |
|
|
2018
Q4 | $665K | Sell |
10,379
-2,856
| -22% | -$183K | 0.19% | 129 |
|
|
2018
Q3 | $1.18M | Buy |
13,235
+4,075
| +44% | +$365K | 0.31% | 83 |
|
|
2018
Q2 | $727K | Sell |
9,160
-1,278
| -12% | -$101K | 0.2% | 126 |
|
|
2018
Q1 | $931K | Buy |
10,438
+5,916
| +131% | +$528K | 0.23% | 105 |
|
|
2017
Q4 | $431K | Sell |
4,522
-441
| -9% | -$42K | 0.11% | 223 |
|
|
2017
Q3 | $724K | Buy |
4,963
+45
| +0.9% | +$6.57K | 0.24% | 104 |
|
|
2017
Q2 | $639K | Sell |
4,918
-2,178
| -31% | -$283K | 0.2% | 120 |
|
|
2017
Q1 | $883K | Sell |
7,096
-500
| -7% | -$62.2K | 0.34% | 63 |
|
|
2016
Q4 | $879K | Sell |
7,596
-1,249
| -14% | -$145K | 0.42% | 49 |
|
|
2016
Q3 | $924K | Buy |
8,845
+4,108
| +87% | +$429K | 0.45% | 51 |
|
|
2016
Q2 | $467K | Sell |
4,737
-220
| -4% | -$21.7K | 0.25% | 103 |
|
|
2016
Q1 | $496K | Buy |
4,957
+213
| +4% | +$21.3K | 0.31% | 88 |
|
|
2015
Q4 | $568K | Sell |
4,744
-29
| -0.6% | -$3.47K | 0.37% | 74 |
|
|
2015
Q3 | $516K | Sell |
4,773
-93
| -2% | -$10.1K | 0.36% | 72 |
|
|
2015
Q2 | $563K | Sell |
4,866
-172
| -3% | -$19.9K | 0.4% | 60 |
|
|
2015
Q1 | $581K | Sell |
5,038
-588
| -10% | -$67.8K | 0.49% | 47 |
|
|
2014
Q4 | $629K | Buy |
5,626
+2,721
| +94% | +$304K | 0.65% | 37 |
|
|
2014
Q3 | $275K | Buy |
+2,905
| New | +$275K | 0.4% | 57 |
|